Industry & Business

Takeda to Invest €25 Million at Grange Castle Site in Dublin

 Breaking News
  • 90 New Jobs at E + I Engineering in Donegal The Taoiseach, Leo Varadkar TD, has announced 90 new jobs at E+I Engineering Ltd in Donegal. E+I Engineering Ltd is a global leader in the critical power distribution sector, manufacturing electrical switchgear, busduct systems and energy management software, for some of the most recognisable brands and technically advanced companies all over the world. Announcing the jobs boost, [...]...
  • €8 Million in Government Funding Awarded by SEAI to Innovative Energy Research Projects The Government has announced €8 million in funding to support 45 innovative energy projects in companies and research institutions across Ireland. The Sustainable Energy Authority of Ireland (SEAI) is responsible for awarding the funding to the 45 projects which aim to develop solutions that will help our homes, businesses and communities deliver a cleaner energy future. [...]...
  • McKeever Hotel Group Renovates Dunadry Hotel in Multi-million Pound Investment McKeever Hotel Group, one of Northern Ireland’s largest family hotel groups, is undertaking a multi-million pound investment designed to revitalise the Dunadry Hotel to a four star, luxury business and leisure venue. The acquisition of the Dunadry Hotel last year was the 5th property to be added to the McKeever Hotel Group portfolio which,  also purchased [...]...
  • Resilient Performance by Breedon Group Breedon Group, a leading construction materials group in the UK and Ireland, has reported revenue of £378.4 million for the six months to 30 June 2018, up from £326.3 million in the corresponding period of 2017. Underlying earnings before interest and tax (EBIT) increased by 17% to £42.0 million. However, excluding acquisitions, both revenue and [...]...
  • 250 New Jobs Announced by Alchemy in Major Investment in Northern Ireland Alchemy Technology Services has announced it is setting up a European Centre of Excellence in Londonderry. It will provide software implementation and technology consultancy to the UK and European insurance sector. The company will provide certified staff to System Integrators, Software Providers and insurance companies for the implementation of digital solutions across the insurance industry. To [...]...

Takeda to Invest €25 Million at Grange Castle Site in Dublin

Takeda to Invest €25 Million at Grange Castle Site in Dublin
March 05
11:57 2018

Takeda Pharmaceutical Company is to create up to 70 new jobs and invest €25 million in the construction of a new regenerative medicine facility at its site in Grange Castle. The investment by Takeda will expand their Grange Castle site’s existing footprint, with the construction of a new standalone modular cell therapy facility dedicated to manufacturing a novel stem cell therapy. The investment will also create 70 temporary construction jobs.

The facility will be in commercial operation by 2021. This investment is supported by the Irish Government through IDA Ireland.

The largest pharmaceutical company in Japan, Takeda first set up operations in Ireland in 1997 manufacturing products for global markets. In 2002 Takeda chose Dublin as the location for its first active pharmaceutical ingredient (API) facility outside of Japan. In 2017 Takeda also announced a €40 million investment in the construction of a stand-alone production facility for the manufacture of part of their Oncology portfolio at Grange Castle.

Welcoming the announcement Pat Breen TD, Minister of State at the Department of Enterprise and Innovation, said: “The pharma industry makes a huge contribution to the Irish economy in terms of jobs and exports, and is one of the fastest growing sectors. Takeda’s decision to invest in Ireland is a great win and vote of confidence in Ireland and it builds on our ongoing expansion of the sector here. I’m delighted that this investment will bring a further 70 jobs to the company’s existing Clondalkin facility.”

Paul Keogh, Plant Director at Takeda Ireland Grange Castle, said that the additional investment in Ireland demonstrates the confidence and commitment Takeda has in its Irish operation. “To be chosen as the first site to introduce this new technology platform to our manufacturing network is very exciting. The nature of this product and its process will bring us closer to the patient than ever before which is a responsibility that we take very seriously. We have a great team here in Ireland and are committed to continuing to put patients first through the timely manufacture and supply of high quality products from our site. The roles being created are in the areas of quality, manufacturing and engineering.”

Martin Shanahan, CEO of IDA Ireland, said: “Ireland is a globally recognised centre of excellence in Life sciences due to the country’s strong regulatory track record and talent availability. The investment by Takeda demonstrates their continued commitment to Ireland.”

About Author

admin

admin

Related Articles

New Subscriber





Subscribe Here



Advertisements



















National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories



Upcoming Events

  • No upcoming events
AEC v1.0.4